The anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor

Molecular Pharmacology

Volumn 63, Issue 1, 2003, Pages 203-210

  Vermeire, Kurt ^a   Bell, Thomas W ^b   Choi, Heung Jin ^c   Jin, Qi ^b   Samala, Meinrado F ^b   Sodoma, Andrej ^d   De Clercq, Erik ^a   Schols, Dominique ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF NEVADA   (United States)

^c Kyungpook National University   (South Korea)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 BENZYL 3 METHYLENE 1,5 DI 4 TOLUENESULFONYL 1,5,9 TRIAZACYCLODODECANE; ANTIVIRUS AGENT; CD4 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; DRUG POTENCY; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE;

ANTI-HIV AGENTS; ANTIGENS, CD4; CELLS, CULTURED; DOWN-REGULATION; HETEROCYCLIC COMPOUNDS, 1-RING; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; STATISTICS; SULFONAMIDES;

EID: 0037220770     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.1.203     Document Type: Article

References (27)

1. Acres RB, Conlon PJ, Mochizuki DY, and Gallis B (1986) Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem 261:16210-16214.
2. Choi H-J (1989) Synthesis and Properties of Polycyclic Triamines and Application of Ionophores to Ion-Selective Electrodes. Ph.D. thesis, State University of New York, Stony Brook, NY.
3. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, and Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (Lond) 312:763-767.
4. Dumonceaux J, Nisole S, Chanel C, Quivet L, Amara A, Baleux F, Briand P, and Hazan U (1998) Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 72:512-519.
5. Edwards TG, Hoffman TL, Baribaud F, Wyss S, LaBranche CC, Romano J, Adkinson J, Sharron M, Hoxie JA, and Doms RW (2001) Relationships between CD4 independence, neutralization sensitivity and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 75:5230-5239.
6. + T cells. J Immunol 152:5768-5775.
7. Hoffman TL, LaBranche CC, Zhang W, Canziani G, Robinson J, Chaiken I, Hoxie JA, and Doms RW (1999) Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc Natl Acad Sci USA 96:6359-6364.
8. Jin Q (1997) Synthesis of CADA Analogs as Potential Antiviral Agents. Ph.D. thesis, University of Nevada, Reno, NV.
9. Kabat D, Kozak SL, Wehrly K, and Chesebro B (1994) Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol 68:2570-2577.
10. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, and Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (Lond) 312:767-768.
11. Kolchinsky P, Kiprilov E, and Sodroski J (2001) Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants. J Virol 75:2041-2050.
12. Kolchinsky P, Mirzabekov T, Farzan M, Kiprilov E, Cayabyab M, Mooney LJ, Choe H, and Sodroski J (1999) Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. J Virol 73:8120-8126.
13. Kozak SL, Platt EJ, Madani N, Ferro FE Jr, Peden K, and Kabat D (1997) CD4, CXCR-4 and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 71:873-882.
14. LaBranche CC, Hoffman TL, Romano J, Haggarty BS, Edwards TG, Matthews TJ, Doms RW, and Hoxie JA (1999) Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J Virol 73:10310-10319.
15. Layne SP, Merges MJ, Dembo M, Spouge JL, and Nara PL (1990) HIV requires multiple gp120 molecules for CD4-mediated infection. Nature (Lond) 346:277-279.
16. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, and Gallo RC (1994) CD4 is a critical component of the receptor for human herpesvirus 7: Interference with human immunodeficiency virus. Proc Natl Acad Sci USA 91:3872-3876.
17. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, and Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
18. Pelchen-Matthews A, Armes JE, Griffiths G, and Marsh M (1991) Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J Exp Med 173:575-587.
19. Pelchen-Matthews A, Boulet I, Littman DR, Fagard R, and Marsh M (1992) The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J Cell Biol 117:279-290.
20. Piguet V, Schwartz O, Le Gall S, and Trono D (1999) The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol Rev 168:51-63.
21. Platt EJ, Madani N, Kozak SL, and Kabat D (1997) Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor. J Virol 71:883-890.
22. Samala MF (1999) Macrocyclic and Open-Chain Analogs of Cycloazadisulfonamide (CADA) as Potential Antiviral Agents. Ph.D. thesis, University of Nevada, Reno, NV.
23. Schols D, Baba M, Pauwels R, Desmyter J, and De Clercq E (1989) Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc Natl Acad Sci USA 86:3322-3326.
24. Sodoma A (1996) A Study Directed Towards the Synthesis of a Macrocycle Exhibiting Möbius Topology and Synthesis of Triazacyclododecanes Possessing Antiviral Properties. Ph.D. thesis, State University of New York, Stony Brook, NY.
25. Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, et al. (2002) CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. Virology 302:342-353.
26. Weiss A and Littman DR (1994) Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
27. Zuniga-Pflucker JC, McCarthy SA, Weston M, Longo DL, Singer A, and Kruisbeek AM (1989) Role of CD4 in thymocyte selection and maturation. J Exp Med 169:2085-2096.